Pradaxa Tops List of Dangerous Drugs in 2011
6/9/2012 12:20 PM EST
Consumers and health professionals singled out the dangers of Pradaxa (Dabigatran)to the Food and Drug Administration more any other medication in 2011, further underscoring the concerns of many that the blood thinner is unsafe.
The QuarterWatch medical surveillance program, which is run by the Institute for Safe Medication Practices, is designed to keep track of any serious and/or fatal adverse drug events that the FDA receives through its MedWatch reporting system, Philly.com reported.
In 2011, the program saw more reports linked to Pradaxa use than any other monitored medication in a number of categories. They include:
- Overall number of reports: 3,781
- Number of deaths: 542
- Hemorrhage cases: 2,367
- Cases of acute renal failure: 291
- Cases of stroke: 644
Pradaxa use was also mentioned in 15 reported cases of liver failure.
Healthcare practitioners also singled out Pradaxa as a leading suspect in adverse medical events more than any other drug with 817 reports. It was followed by Coumadin (Warfarin) with 490, Levaquin (Levofloxacin) with 393, Carboplatin with 376, and Zestril (Lisinopril) with 351 reports.
If you or a loved one has been hurt by Pradaxa use, call Sokolove Law today to learn more about potentially pursuing a dangerous drug lawsuit.